Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE HEALTH — Investor Presentation (May 2022)
17 slides from Scienture's investor presentation, May 9, 2022
Slide 1: Digitalizing the Retail Pharmacy Experience
ewe Digitalizing the Retail Pharn macy Experience t Investor Presentation ‘a May 2022 NASDAQ:MEDS
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information set forth herein contains forward-looking statements within the federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to
Slide 3: About TRxADE HEALTH, INC.
About TRxXADE HEALTH, INC. TRXADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. * Market Leader: Operates one of the largest technology platfo
Slide 4: Divisions of TRxADE HEALTH
Divisions of TRXADE HEALTH Pharmaceutical Marketplaces (With Supporting B2B + Supplier-Pharmacy Marketplace Platform SOSRx —— Manufacturer-Distributor Marketplace Platform sittin, HIE Rx Distributor 1) Pie slices not representative of revenue mix between subsidiaries vy BONUM HEALTH KN Community Spe
Slide 5: TRxADE Marketplace
TRxADE Marketplace Our B2B Pharmaceutical Supply Chain Platform U.S. Pharmaceutical Industry?? * Projected $685B per year industry size by 2023 and growing; Over 65,000 pharmacy facilities «Approximately 9 out of 10 Americans live within 5 miles of a community pharmacy * Excluding several large nati
Slide 6: TRxADE Marketplace
TRXADE Marketplace Trxade.com (Distributor Pharmaceutical Supply Chain Platform) Our Marketplace Solution: *TRxADE’s exchange platform offers a clear and concise interface that allows over 13,400+ registered members in 50 states to analyze “up- to-the-minute” supply & pricing from multiple pharma su
Slide 7: TRxADE Marketplace: SOSRx.com
TRXADE Marketplace SOSRx.com (Manufacturer Pharmaceutical Supply Chain Platform) Our Marketplace Solution: *The US Generic drug market reached $127.8 Billion in 2020." *A percentage of products become short dated, overstock or slow moving over time and become off contract *SOSRx marketplace is an in
Slide 8: TRxADE's Revenue Model
TRxADE’s Revenue Model TRxADE Platform An administrative fee of up to 6 percent of the buying price on generic pharmaceuticals and up to 1 percent on brand pharmaceuticals that pass through our platform. SOSRx An administrative fee of up to 20 percent paid by the manufacturer of the purchase price o
Slide 9: Selected Operational Metrics
Selected Operational Metrics TRXADE Platform TRXADE Prime Our marketplace has over 72 national and regional The focus of Trxade Prime is to be the pharmaceutical pharmaceutical suppliers providing over 120,000 supplier of choice for healthcare organizations of all sizes. branded and generic drugs, i
Slide 10: Marketplace User Supporting Divisions
Marketplace User Supporting Divisions HEALTH rows Bonum Health Tele Health Company offers individual and Employer sponsored patients access to certified medical providers 24/7/365 in 50 states * Focus on uninsured and underinsured patients * Has Partnerships with 1,000+ Retail chain and independent
Slide 11: Selected Financials
Selected Financials a Quarterly Revenue Growth (USD $ in Thousands) * High Margin: Revenue from transaction fees on marketplace platform 37240 (Credit Card/PayPal model) does not include the drugs value (over $100M — apne 2,388 annually), hence “tech like margins” z * Built-Out Platform: 13,400+ reg
Slide 12: Management
Management Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Ajjarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of Trxade Group, Inc., a Nevada corporation (“TRXADE Nevada”) (our predecessor company) on January 8, 2014, and a
Slide 13: Key Takeaways
Key Takeaways NASDAQ:MEDS TRXADE is a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. A Tech Focused Healthcare Services Company * Market Leader: Ope
Slide 14: Contact Us
Contact Us TRXADE HEALTH, INC. 2420 Brunello Trace Lutz , FL 34558 (800) 261-0281 www.trxadehealth.com @TRADE
Slide 15: Appendix: Consolidated Balance Sheet
Appendix: Consolidated Balance Sheet fiat DRANG! Consolidated Balance Sheets March 31, 2022 and December 31, 2021 March 31, December 31, March 31, 2021 Assets Liabilities and Shareholders Equit Current Assets Current Liabilities Cash S$ igmem $ 310578 ‘Accounts Payable 908.495 471008 Accounts Receiv
Slide 16: Appendix: Consolidated Statements of Operations
Appendix: Consolidated Statements of Operations TRxADE HEALTH, INC. Consolidated Statements of Operations For the Three Months Ended March 31, 2022, and 2021 (unaudited) Revenues Cost of Sales Gross Profit Operating Expense ‘Wage and Salary Expense Professional Fees Accounting and Legal Expense Tech
Slide 17: Appendix: Reconciliation of Net Income to Adj. EBITDA
aly) Appendix: Reconciliation of Net Income to Adj. EBITDA* * EBITDA and Adjusted EBITDA are non-GAAP financial measures. These measurements are not recognized in accordance with GAAP and should not be viewed as an Reconciliation of Net Income(Loss) attributable to TRXADE HEALTH, Inc., to Earnings b